Cape Investment Advisory’s Zomedica Corp. ZOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-12,000
Closed -$1.44K 1205
2024
Q4
$1.44K Hold
12,000
﹤0.01% 916
2024
Q3
$1.65K Hold
12,000
﹤0.01% 844
2024
Q2
$1.75K Hold
12,000
﹤0.01% 800
2024
Q1
$1.75K Hold
12,000
﹤0.01% 784
2023
Q4
$2.4K Hold
12,000
﹤0.01% 902
2023
Q3
$2K Hold
12,000
﹤0.01% 787
2023
Q2
$2.4K Hold
12,000
﹤0.01% 755
2023
Q1
$2.54K Buy
+12,000
New +$2.94K ﹤0.01% 786

Other funds holding ZOM

Cape Investment Advisory's ZOM Position: Q1 2025 in Review

Cape Investment Advisory sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 12,000 shares — an estimated $1.44K sold.

Cape Investment Advisory first reported a position in ZOM in Q1 2023 and held it in 8 quarters. The position peaked at $2.54K in Q1 2023. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • Cape Investment Advisory reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • Cape Investment Advisory sold 12,000 Zomedica Corp. shares in Q1 2025, an estimated $1.44K.
  • Cape Investment Advisory first reported a position in Zomedica Corp. in Q1 2023 and held it in 8 quarters.
  • Cape Investment Advisory's Zomedica Corp. position peaked at $2.54K in Q1 2023.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on Cape Investment Advisory's 13F filing for Q1 2025, filed 16 May 2025.